LLY

910.17

+0.51%↑

UNH

569.99

-0.12%↓

NVO

116.46

-0.73%↓

JNJ

163.54

+0.57%↑

ABBV

188.97

+1.46%↑

LLY

910.17

+0.51%↑

UNH

569.99

-0.12%↓

NVO

116.46

-0.73%↓

JNJ

163.54

+0.57%↑

ABBV

188.97

+1.46%↑

LLY

910.17

+0.51%↑

UNH

569.99

-0.12%↓

NVO

116.46

-0.73%↓

JNJ

163.54

+0.57%↑

ABBV

188.97

+1.46%↑

LLY

910.17

+0.51%↑

UNH

569.99

-0.12%↓

NVO

116.46

-0.73%↓

JNJ

163.54

+0.57%↑

ABBV

188.97

+1.46%↑

LLY

910.17

+0.51%↑

UNH

569.99

-0.12%↓

NVO

116.46

-0.73%↓

JNJ

163.54

+0.57%↑

ABBV

188.97

+1.46%↑

Kodu・Aktsiate loetelu・ACADIA Pharmaceuticals Inc

ACADIA Pharmaceuticals Inc

Suletud

Sektor Tervishoid

14.55 -1.36

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

14.53

Max

14.89

Põhinäitajad
By Trading Economics
Sissetulek	17M 33M
Müük	36M 242M
Aktsiakasum	0.2
Kasumimarginaal	13.797
Töötajad	597
EBITDA	12M 33M

Soovitused
By TipRanks
Soovitused	Osta
12 kuu keskmine prognoos	+74.46 upside

Dividendid
By Dow Jones
Järgmine tulemuste avaldamine	6. nov 2024

Turustatistika
By TradingEconomics
Turukapital	-46M 2.5B
Eelmine avamishind	15.91
Eelmine sulgemishind	14.55

Uudiste sentiment

By Acuity

20%

80%

31 / 390 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Bullish Evidence

14.45 / 14.92 Toetus ja vastupanu

ACADIA Pharmaceuticals Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

22. okt 2024, 21:55 UTC

Suurimad hinnamuutused turgudel

McDonald's Shares Fall After CDC Says E. Coli Outbreak Linked to Quarter Pounders -- Update

22. okt 2024, 21:48 UTC

Peamised uudised

CDC Says E. Coli Outbreak Linked to McDonald's Quarter Pounders -- Update

22. okt 2024, 21:37 UTC

Suurimad hinnamuutused turgudel

DBV Technologies Rally 47% Following Positive Updates for Peanut Allergy Patch

22. okt 2024, 21:30 UTC

Suurimad hinnamuutused turgudel

McDonald's Shares Fall After CDC Says E. Coli Outbreak Linked to Quarter Pounders

22. okt 2024, 21:12 UTC

Peamised uudised

CDC Says E. Coli Outbreak Linked to McDonald's Quarter Pounders

22. okt 2024, 20:52 UTC

Peamised uudised

Tulu

Starbucks Suspends Guidance After Sales Slump Persists

22. okt 2024, 20:49 UTC

Peamised uudised

Tulu

Canadian National Railway Posts Higher Revenue, Lower Profit in 3Q

22. okt 2024, 20:28 UTC

Tulu

Texas Instruments Posts Lower 3Q Revenue

22. okt 2024, 23:24 UTC

Peamised uudised

Tulu

Starbucks Suspends Guidance as Sales Slump Persists -- 2nd Update

22. okt 2024, 22:54 UTC

Market Talk

Global Equities Roundup: Market Talk

22. okt 2024, 22:53 UTC

Market Talk

CSL's R&D Update Seen as Neutral Overall -- Market Talk

22. okt 2024, 22:46 UTC

Peamised uudised

Meta Bans Accounts That Track Celebrity Jet Travel, Including for Zuckerberg -- WSJ

22. okt 2024, 22:45 UTC

Peamised uudised

McDonald's Quarter Pounders Linked to Deadly E. Coli Outbreak -- 3rd Update

22. okt 2024, 21:58 UTC

Peamised uudised

Tulu

Starbucks Suspends Guidance as Sales Slump Persists -- Update

22. okt 2024, 21:53 UTC

Peamised uudised

McDonald's Quarter Pounders Linked to Deadly E. Coli Outbreak -- 2nd Update

22. okt 2024, 21:19 UTC

Peamised uudised

Texas Instruments' Guidance Falls Short. The Stock Is Rising Anyway. -- Barrons.com

22. okt 2024, 21:14 UTC

Tulu

3M Produces Beat-and-Raise Earnings. The Stock Dropped. -- Barrons.com

22. okt 2024, 21:05 UTC

Peamised uudised

McDonald's Quarter Pounders Linked to Deadly E. Coli Outbreak -- Update

22. okt 2024, 20:55 UTC

Tulu

Philip Morris International Stock Surges to Record -- WSJ

22. okt 2024, 20:50 UTC

Market Talk

Financial Services Roundup: Market Talk

22. okt 2024, 20:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

22. okt 2024, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

22. okt 2024, 20:48 UTC

Peamised uudised

McDonald's Quarter Pounders Linked to Deadly E. Coli Outbreak -- WSJ

22. okt 2024, 20:45 UTC

Peamised uudised

Treasury Yields Rise, S&P 500 Edges Lower After Earnings Flurry -- WSJ

22. okt 2024, 20:45 UTC

Tulu

GE Aerospace Stock Skids Amid Commercial-Engine Concerns -- WSJ

22. okt 2024, 20:34 UTC

Peamised uudised

Tulu

Starbucks Stock Drops After Company Misses Earnings, Suspends Guidance -- Barrons.com

22. okt 2024, 20:22 UTC

Tulu

Nabors: Expects 4Q U.S. Drilling Lower 48 Avg Rig Count of Approximately 68 Rigs >NBR

22. okt 2024, 20:22 UTC

Tulu

Nabors: Expects Full-Yr Cap Expenditures of Approximately $600M, With $230M for the SANAD Newbuilds >NBR

22. okt 2024, 20:22 UTC

Tulu

Nabors: Expects 4Q International Avg Rig Count of Approximately 84 Rigs >NBR

22. okt 2024, 20:22 UTC

Tulu

Nabors: Expects 4Q Cap Expenditures of $230M, With $105M for the Newbuilds in Saudi Arabia >NBR

Võrdlus sarnastega

Hinnamuutus

ACADIA Pharmaceuticals Inc Prognoos

Hinnasiht

By TipRanks

74.46% tõus

12 kuu keskmine prognoos

Keskmine 25.75 USD 74.46%

Kõrge 39 USD

Madal 12 USD

Põhineb 20 Wall Streeti analüütiku instrumendi ACADIA Pharmaceuticals Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

20 ratings

Osta

Hoia

Müü

Põhineb 20 analüütiku instrumendi ACADIA Pharmaceuticals Inc aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

14.45 / 14.92Toetus ja vastupanu

Recent bullish events outweigh bearish events.

There are no events.

Sentiment

By Acuity

31 / 390 Pingereas Tervishoid

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

EBITDA

Ärikasum

Ettevõttest ACADIA Pharmaceuticals Inc

Acadia Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of medicines to address unmet medical needs in central nervous system disorders. The Company's product pipeline includes NUPLAZID (pimavanser), Trofinetide, ACP-044 and ACP-319. NUPLAZID (pimavanserin) is used for the treatment of hallucinations and delusions associated with Parkinson’s disease psychosis (PDP). NUPLAZID is a selective serotonin inverse agonist/antagonist, preferentially targeting 5-HT2A receptors with no appreciable affinity for dopaminergic, histaminergic, or muscarinic receptors. Trofinetide is a synthetic analog of the amino-terminal tripeptide of insulin-like growth factor 1 (IGF-1) designed to treat the core symptoms of Rett syndrome. ACP-044, is an orally administered, non-opioid analgesic being evaluated for the treatment of pain. ACP-319 is a positive allosteric modulator of the muscarinic receptor targeting M1 (M1 PAM).